Secukinumab for the treatment of SAM syndrome associated with desmoglein-1 deficiency.
| Autor: | Frommherz LH; Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Schempp CM; Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Has C; Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The British journal of dermatology [Br J Dermatol] 2021 Apr; Vol. 184 (4), pp. 770-772. Date of Electronic Publication: 2020 Dec 28. |
| DOI: | 10.1111/bjd.19684 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Plný text